- Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2022
- Nomination Committee Appointed for the Annual General Meeting 2023 in Promore Pharma
- Promore Pharma provides an update on the Phase II clinical trial with ensereptide
- Promore Pharma Interim report January – June 2022
- Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Second Quarter 2022
Promore Pharma AB (publ) publishes its interim report for the third quarter 2022 on 29 November 2022.
The day after, the 30 November at 11:00 CET, the company will host a webcast telephone conference with President and CEO Jonas Ekblom, whith an update for the quarter and upcoming activities. After the presentation there will be a Q&A session.